Review: taking Orphenadrine citrate and Vicodin together


Summary

Drug interactions are reported among people who take Orphenadrine citrate and Vicodin together. This review analyzes the effectiveness and drug interactions between Orphenadrine citrate and Vicodin. It is created by eHealthMe based on reports of 261 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Orphenadrine citrate and Vicodin >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Orphenadrine Citrate

Orphenadrine citrate has active ingredients of orphenadrine citrate. It is often used in muscle spasms. (latest outcomes from Orphenadrine citrate 544 users)

Vicodin

Vicodin has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. (latest outcomes from Vicodin 34,634 users)

On Jul, 27, 2016

261 people who take Orphenadrine Citrate, Vicodin are studied.


Number of reports submitted per year:

Orphenadrine citrate and Vicodin drug interactions.

Drug effectiveness over time:

Orphenadrine Citrate:
  • < 1 month: 20.0% - (1 of 5 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 25.0% - (1 of 4 people)
  • not specified: 0.0% - (0 of 0 people)
Vicodin:
  • < 1 month: 33.0% - (1 of 3 people)
  • 1 - 6 months: 20.0% - (1 of 5 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 100.0% - (4 of 4 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Orphenadrine Citrate:
  • female: 30.0% - (3 of 10 people)
  • male: 0.0% - (0 of 2 people)
Vicodin:
  • female: 60.0% - (6 of 10 people)
  • male: 0.0% - (0 of 3 people)

Drug effectiveness by age:

Orphenadrine Citrate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 2 people)
  • 30-39: 33.0% - (1 of 3 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 25.0% - (1 of 4 people)
Vicodin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 2 people)
  • 30-39: 33.0% - (1 of 3 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 100.0% - (4 of 4 people)

Most common drug interactions over time *:

< 1 month:
  • constipation
  • dizziness
  • nausea
  • vaginal discharge
  • abdominal pain upper
  • cholecystitis chronic
  • gastric haemorrhage
  • gastrointestinal haemorrhage
  • injury
  • intestinal haemorrhage
1 - 6 months:
  • pain
  • pulmonary embolism
  • anxiety
  • cholecystitis chronic
  • decreased appetite
  • depression
  • dyspnoea
  • feeling jittery
  • injury
  • insomnia
6 - 12 months:
  • confusional state
  • pulmonary embolism
1 - 2 years:
  • pain
  • pain - leg
2 - 5 years:
  • abscess
  • actinomycosis
  • agitation
  • anaemia
  • anxiety
  • arthralgia
  • arthritis
  • back pain
  • barrett's oesophagus
  • beta haemolytic streptococcal infection
5 - 10 years:
  • completed suicide
  • depression
10+ years:
  • anxiety and stress
  • bipolar 1
  • heart disease - aging
  • hypertension
  • hypothyroidism
  • migraine
  • muscle contracture
  • pain exacerbated
  • acute brain syndrome, acute confusional state, delirium
  • confusion
not specified:
  • pain
  • anxiety
  • depression
  • back pain
  • fall
  • arthralgia
  • dyspnoea
  • diarrhoea
  • oedema peripheral
  • muscle spasms

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • back pain
  • dyspnoea
  • fall
  • arthralgia
  • diarrhoea
  • depression
  • dry mouth
  • pain in extremity
male:
  • depression
  • suicidal ideation
  • drug ineffective
  • drug withdrawal syndrome
  • anxiety
  • drug dependence
  • emotional distress
  • insomnia
  • back pain
  • pain

Most common drug interactions by age *:

10-19:
  • cholelithiasis
  • gallbladder disorder
  • injury
20-29:
  • drug withdrawal syndrome
  • suicidal ideation
  • oedema peripheral
  • anxiety
  • cholelithiasis
  • dehydration
  • hypocalcaemia
  • hypokalaemia
  • paraplegia
  • weight decreased
30-39:
  • pain
  • emotional distress
  • oedema peripheral
  • drug withdrawal syndrome
  • arthralgia
  • anxiety
  • dyspnoea
  • nausea
  • insomnia
  • irritability
40-49:
  • depression
  • arthralgia
  • muscle spasms
  • fall
  • dyspnoea
  • pain
  • chest pain
  • palpitations
  • vision blurred
  • asthenia
50-59:
  • back pain
  • dyspnoea
  • headache
  • arthralgia
  • pain
  • anxiety
  • depression
  • pain in extremity
  • hypotension
  • pyrexia
60+:
  • anxiety
  • pain
  • diarrhoea
  • fall
  • skin ulcer
  • gastrooesophageal reflux disease
  • obesity
  • gastritis
  • road traffic accident
  • pruritus

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Orphenadrine citrate and Vicodin?

Can you answer these questions?

More questions for: Orphenadrine citrate, Vicodin

You may be interested in these reviews

More reviews for: Orphenadrine citrate, Vicodin

On eHealthMe, Orphenadrine citrate (orphenadrine citrate) is often used to treat muscle spasms. Vicodin (acetaminophen; hydrocodone bitartrate) is often used to treat pain. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.